David Luo
Overview
Explore the profile of David Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
610
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salerno-Goncalves R, Rezwan T, Luo D, Tettelin H, Sztein M
Front Immunol
. 2021 Oct;
12:728685.
PMID: 34659215
Mucosal-associated invariant T (MAIT) cells are an innate-like population of T cells that display a TCR Vα7.2+ CD161+ phenotype and are restricted by the nonclassical MHC-related molecule 1 (MR1). Although...
2.
Salerno-Goncalves R, Tettelin H, Luo D, Guo Q, Ardito M, Martin W, et al.
Vaccine
. 2019 Oct;
38(2):258-270.
PMID: 31629569
It is widely accepted that CD4 and CD8 T-cells play a significant role in protection against Salmonella enterica serovar Typhi (S. Typhi), the causative agent of the typhoid fever. However,...
3.
Sigal D, Tartar M, Xavier M, Bao F, Foley P, Luo D, et al.
J Natl Compr Canc Netw
. 2017 Nov;
15(11):1317-1322.
PMID: 29118225
Despite advances in genomic analysis, the molecular origin of neuroendocrine tumors (NETs) is complex and poorly explained by described oncogenes. The neurotrophic TRK family, including 1, 2, and 3, encode...
4.
Salerno-Goncalves R, Luo D, Fresnay S, Magder L, Darton T, Jones C, et al.
Front Immunol
. 2017 Apr;
8:398.
PMID: 28428786
Gastrointestinal infections by serovar Typhi (. Typhi) are rare in industrialized countries. However, they remain a major public health problem in the developing world with an estimated 26.9 million new...
5.
Drilon A, Siena S, Ou S, Patel M, Ahn M, Lee J, et al.
Cancer Discov
. 2017 Feb;
7(4):400-409.
PMID: 28183697
Entrectinib, a potent oral inhibitor of the tyrosine kinases TRKA/B/C, ROS1, and ALK, was evaluated in two phase I studies in patients with advanced or metastatic solid tumors, including patients...
6.
Maione B, Luo D, Miskiewicz M, Escuti M, Kudenov M
Appl Opt
. 2016 Nov;
55(31):8667-8675.
PMID: 27828259
Snapshot hyperspectral imaging Fourier transform (SHIFT) spectrometers are a promising technology in optical detection and target identification. For any imaging spectrometer, spatial, spectral, and temporal resolution, along with form factor,...
7.
Luo D, Kudenov M
Opt Express
. 2016 Jul;
24(10):11266-81.
PMID: 27409947
Systematic phase errors in Fourier transform spectroscopy can severely degrade the calculated spectra. Compensation of these errors is typically accomplished using post-processing techniques, such as Fourier deconvolution, linear unmixing, or...
8.
Amatu A, Somaschini A, Cerea G, Bosotti R, Valtorta E, Buonandi P, et al.
Br J Cancer
. 2015 Dec;
113(12):1730-4.
PMID: 26633560
Background: Activated anaplastic lymphoma kinase (ALK) gene fusions are recurrent events in a small fraction of colorectal cancers (CRCs), although these events have not yet been exploited as in other...
9.
Farago A, Le L, Zheng Z, Muzikansky A, Drilon A, Patel M, et al.
J Thorac Oncol
. 2015 Nov;
10(12):1670-4.
PMID: 26565381
Introduction: Chromosomal rearrangements involving neurotrophic tyrosine kinase 1 (NTRK1) occur in a subset of non-small cell lung cancers (NSCLCs) and other solid tumor malignancies, leading to expression of an oncogenic...
10.
Sartore-Bianchi A, Ardini E, Bosotti R, Amatu A, Valtorta E, Somaschini A, et al.
J Natl Cancer Inst
. 2015 Nov;
108(1).
PMID: 26563355
In metastatic colorectal cancer (CRC), actionable genetic lesions represent potential clinical opportunities. NTRK1, 2, and 3 gene rearrangements encode oncogenic fusions of the tropomyosin-receptor kinase (TRK) family of receptor tyrosine...